Literature DB >> 11237531

p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.

J Philipp-Staheli1, S R Payne, C J Kemp.   

Abstract

A major function of p27, also known as Kip1, is to bind and inhibit cyclin/cyclin-dependent kinase complexes, thereby blocking cell cycle progression. As p27 operates at the heart of the cell cycle, it is perhaps not surprising that it is emerging as a key player in multiple cell fate decisions including proliferation, differentiation, and cell death. The central role of p27 makes it important in a variety of disease processes that involve aberrations in cellular proliferation and other cell fates. Most notable among these processes is neoplasia. A large number of studies have reported that p27 expression is frequently downregulated in human tumors. In most tumor types, reduced p27 expression correlates with poor prognosis, making p27 a novel and powerful prognostic marker. In addition to these practical implications, murine and tissue culture models have shown that p27 is a potent tumor suppressor gene for multiple epithelially derived neoplasias. Loss of p27 cooperates with mutations in several oncogenes and tumor suppressor genes to facilitate tumor growth, indicating that p27 may be a "nodal point" for tumor suppression. In contrast to most tumor suppressor genes studied to date, which are recessive at the cellular level, p27 is haploinsufficient for tumor suppression. The fact that tumor suppression by p27 is critically dependent on the absolute level of p27 expression indicates that p27 acts as a rheostat rather than as an on/off switch to control growth and neoplasia. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237531     DOI: 10.1006/excr.2000.5143

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  91 in total

1.  Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer.

Authors:  Markus D Lacher; Roxana J Pincheira; Ariel F Castro
Journal:  Small GTPases       Date:  2011-07-01

2.  Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.

Authors:  Jianfeng Xu; Carl D Langefeld; S Lilly Zheng; Elizabeth M Gillanders; Bao-Li Chang; Sarah D Isaacs; Adrienne H Williams; Kathy E Wiley; Latchezar Dimitrov; Deborah A Meyers; Patrick C Walsh; Jeffrey M Trent; William B Isaacs
Journal:  Hum Genet       Date:  2004-06-05       Impact factor: 4.132

Review 3.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

4.  Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.

Authors:  Amer M Mirza; Stephan Gysin; Nisar Malek; Kei-ichi Nakayama; James M Roberts; Martin McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

5.  Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.

Authors:  Shojiro Kitajima; Yasusei Kudo; Ikuko Ogawa; Tarig Bashir; Masae Kitagawa; Mutsumi Miyauchi; Michele Pagano; Takashi Takata
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 6.  Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Authors:  Elizabeth A Musgrove; Elizabeth A Davison; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

7.  Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.

Authors:  Nicholas F S Watson; Lindy G Durrant; John H Scholefield; Zahra Madjd; Duncan Scrimgeour; Ian Spendlove; Ian O Ellis; Poulam M Patel
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

9.  A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.

Authors:  Arnaud Besson; Mark Gurian-West; Xueyan Chen; Karen S Kelly-Spratt; Christopher J Kemp; James M Roberts
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

10.  p27Kip1 modulates cell migration through the regulation of RhoA activation.

Authors:  Arnaud Besson; Mark Gurian-West; Anja Schmidt; Alan Hall; James M Roberts
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.